Clinical Trials Directory

Double-blind, Randomized, Placebo-controlled Two-period Crossover Study to Assess the Effect of Levocarnitine on Vismodegib-associated Muscle Spasms

This randomized clinical trial studies levocarnitine in treating patients with vismodegib-associated muscle spasms. Levocarnitine may decrease muscle spasms caused by vismodegib.

Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.

Investigator(s):

Intervention(s):

  • dietary supplement : levocarnitine
  • other : questionnaire administration
  • other : placebo

Phase: N/A

Eligibility

Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

- Taking vismodegib daily - Subject answers item #1 of muscle spasms questionnaire as moderate or severe intensity at time of screening - At least one muscle spasm per day at time of screening - Muscle spasms onset after starting vismodegib - Willing and able to understand and sign consent form

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Anne Lynn Chang
650-721-7151
Recruiting

Footer Links: